1086 related articles for article (PubMed ID: 24411704)
1. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
2. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
3. Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study.
Coburger J; König R; Seitz K; Bäzner U; Wirtz CR; Hlavac M
J Neurosurg; 2014 Feb; 120(2):346-56. PubMed ID: 24329023
[TBL] [Abstract][Full Text] [Related]
4. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.
Kuhnt D; Becker A; Ganslandt O; Bauer M; Buchfelder M; Nimsky C
Neuro Oncol; 2011 Dec; 13(12):1339-48. PubMed ID: 21914639
[TBL] [Abstract][Full Text] [Related]
6. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the Extent of Resection and Minimizing the Morbidity in Insular High-Grade Glioma Surgery by High-Field Intraoperative MRI Guidance.
Chen LF; Yang Y; Ma XD; Yu XG; Gui QP; Xu BN; Zhou DB
Turk Neurosurg; 2017; 27(5):696-706. PubMed ID: 27651342
[TBL] [Abstract][Full Text] [Related]
8. Low field intraoperative MRI-guided surgery of gliomas: a single center experience.
Senft C; Franz K; Ulrich CT; Bink A; Szelényi A; Gasser T; Seifert V
Clin Neurol Neurosurg; 2010 Apr; 112(3):237-43. PubMed ID: 20036049
[TBL] [Abstract][Full Text] [Related]
9. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
[TBL] [Abstract][Full Text] [Related]
10. Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery.
Roder C; Breitkopf M; Ms ; Bisdas S; Freitas Rda S; Dimostheni A; Ebinger M; Wolff M; Tatagiba M; Schuhmann MU
Neurosurg Focus; 2016 Mar; 40(3):E13. PubMed ID: 26926053
[TBL] [Abstract][Full Text] [Related]
11. Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging.
Coburger J; Wirtz CR; König RW
J Neurosurg Sci; 2017 Jun; 61(3):233-244. PubMed ID: 26149222
[TBL] [Abstract][Full Text] [Related]
12. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
[TBL] [Abstract][Full Text] [Related]
13. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
14. Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme.
Senft C; Franz K; Blasel S; Oszvald A; Rathert J; Seifert V; Gasser T
Technol Cancer Res Treat; 2010 Aug; 9(4):339-46. PubMed ID: 20626200
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
[TBL] [Abstract][Full Text] [Related]
16. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
17. [Application of intraoperative magnetic resonance imaging and multimodal navigation in surgical resection of glioblastoma].
Li FY; Chen XL; Sai XY; Zhang JS; Hu S; Li JJ; Zheng G; Zhang T; Li Y; Hou MZ; Xu BN
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):542-6. PubMed ID: 24091271
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery.
Schatlo B; Fandino J; Smoll NR; Wetzel O; Remonda L; Marbacher S; Perrig W; Landolt H; Fathi AR
Neuro Oncol; 2015 Dec; 17(12):1560-7. PubMed ID: 25858636
[TBL] [Abstract][Full Text] [Related]
19. Dual-Use Intraoperative MRI in Glioblastoma Surgery: Results of Resection, Histopathologic Assessment, and Surgical Site Infections.
Wach J; Goetz C; Shareghi K; Scholz T; Heßelmann V; Mager AK; Gottschalk J; Vatter H; Kremer P
J Neurol Surg A Cent Eur Neurosurg; 2019 Nov; 80(6):413-422. PubMed ID: 31272122
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.
Roder C; Stummer W; Coburger J; Scherer M; Haas P; von der Brelie C; Kamp MA; Löhr M; Hamisch CA; Skardelly M; Scholz T; Schipmann S; Rathert J; Brand CM; Pala A; Ernemann U; Stockhammer F; Gerlach R; Kremer P; Goldbrunner R; Ernestus RI; Sabel M; Rohde V; Tabatabai G; Martus P; Bisdas S; Ganslandt O; Unterberg A; Wirtz CR; Tatagiba M
J Clin Oncol; 2023 Dec; 41(36):5512-5523. PubMed ID: 37335962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
